nanrilkefusp alfa (formerly SOT101), an IL-15 superagonist

Indicaton

Solid tumors

Therapeutic indications

Oncology

Type of product

Table

Phase

Phase II started
Partnering status

Not partnered
Available in

Europe, US

You may also be interested in

Herzuma (trastuzumab)

Multiple indications in metastatic breast cancer, early breast cancer and metastatic gastric cancer

Marketed

Truxima (rituximab)

Multiple indications in Non-Hodgkin's lymphoma (NHL), Chronic lymphocytic leukaemia (CLL), Rheumatoid arthritis, Granulomatosis with polyangiitis and microscopic polyangiitis and Pemphigus vulgaris

Marketed

3D CoSeedis in chip Assays

Preclinical 3D Study models for oncology and neurology.

Marketed